They showed that type I interferon (IFN)-responsive cDC2s (IFN-stimulated genes [ISG+] DCs) externally express tumor-derived MHC class I molecules (“MHC-I dressing”), and MHC-I-dressed ISG+ DCs can activate CD8+ T cells [55]. The gene discussed is CD8A; the disease is neoplasm.